Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical School, shared a post on X:
“Packed educational session on novel ADCs at ASCO26.
So much potential in this drug class, yet many challenges to address, including optimal combos and sequences. A honor to share the stage with my mentor and friend G Curigliano and with a legend of ADC development Tony Tolcher.”
Other articles Paolo Tarantino on OncoDaily.
